Pharmacokinetics of the Oral Selective CXCR2 Antagonist AZD5069: A Summary of Eight Phase I Studies in Healthy Volunteers von Cullberg, Marie, Arfvidsson, Cecilia, Larsson, Bengt, Malmgren, Anna, Mitchell, Patrick, Wählby Hamrén, Ulrika, Wray, Heather

Volltext

Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants von Wilkins, Deidre, Yuan, Yuan, Chang, Yue, Aksyuk, Anastasia A., Núñez, Beatriz Seoane, Wählby-Hamrén, Ulrika, Zhang, Tianhui, Abram, Michael E., Leach, Amanda, Villafana, Tonya, Esser, Mark T.

Volltext

Pharmacokinetics of the Inhaled Selective Glucocorticoid Receptor Modulator AZD5423 Following Inhalation Using Different Devices von Melin, Johanna, Prothon, Susanne, Kloft, Charlotte, Cleton, Adriaan, Amilon, Carl, Jorup, Carin, Bäckman, Per, Olsson, Bo, Hamrén, Ulrika Wählby

Volltext

Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants von Hammitt, Laura L, Dagan, Ron, Yuan, Yuan, Baca Cots, Manuel, Bosheva, Miroslava, Madhi, Shabir A, Muller, William J, Zar, Heather J, Brooks, Dennis, Grenham, Amy, Wählby Hamrén, Ulrika, Mankad, Vaishali S, Ren, Pin, Takas, Therese, Abram, Michael E, Leach, Amanda, Griffin, M. Pamela, Villafana, Tonya

Volltext

Pharmacokinetic-pharmacodynamic modeling of fostamatinib efficacy on ACR20 to support dose selection in patients with rheumatoid arthritis (RA) von Maringwa, John, Kågedal, Matts, Hamrén, Ulrika Wählby, Martin, Paul, Cox, Eugène, Hamrén, Bengt

Volltext

RSV Neutralizing Antibodies Following Nirsevimab and Palivizumab Dosing von Wilkins, Deidre, Wählby Hamrén, Ulrika, Chang, Yue, Clegg, Lindsay E, Domachowske, Joseph, Englund, Janet A, Muller, William J, Leach, Amanda, Kelly, Elizabeth J, Villafana, Tonya

Volltext

Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trials von Ahani, Bahar, Tuffy, Kevin M., Aksyuk, Anastasia A., Wilkins, Deidre, Abram, Michael E., Dagan, Ron, Domachowske, Joseph B., Guest, Johnathan D., Ji, Hong, Kushnir, Anna, Leach, Amanda, Madhi, Shabir A., Mankad, Vaishali S., Simões, Eric A. F., Sparklin, Benjamin, Speer, Scott D., Stanley, Ann Marie, Tabor, David E., Hamrén, Ulrika Wählby, Kelly, Elizabeth J., Villafana, Tonya

Volltext

Molecular and phenotypic characteristics of respiratory syncytial virus isolates recovered from medically vulnerable children: An exploratory analysis of a phase 2/3 randomized, do... von Tuffy, Kevin M., Ahani, Bahar, Domachowske, Joseph B., Furuno, Kenji, Ji, Hong, Madhi, Shabir A., Mankad, Vaishali S., Hamrén, Ulrika Wählby, Villafana, Tonya, Wang, Yingyi, Kelly, Elizabeth J., Wilkins, Deidre

Volltext

A Randomized Trial of Dual-Acting Bronchodilator AZD8871 for Chronic Obstructive Pulmonary Disease von Singh, Dave, Fuhr, Rainard, Jimenez, Lali, Wählby Hamrén, Ulrika, Jauhiainen, Alexandra, Malice, Marie-Pierre, Balaguer, Victor, Lei, Alejhandra, Aggarwal, Ajay, Astbury, Carol, Psallidas, Ioannis

Volltext

Characterization of Clinical Absorption, Distribution, Metabolism, and Excretion and Pharmacokinetics of Velsecorat Using an Intravenous Microtracer Combined with an Inhaled Dose i... von Holmberg, Ann Aurell, Weidolf, Lars, Necander, Sofia, Bold, Peter, Sidhu, Sharan, Pelay-Gimeno, Marta, de Ligt, Rianne A F, Verheij, Elwin R, Jauhiainen, Alexandra, Psallidas, Ioannis, Wählby Hamrén, Ulrika, Prothon, Susanne

Volltext

Safety, pharmacokinetics and pharmacodynamics of the selective glucocorticoid receptor modulator AZD7594, following inhalation in healthy Japanese volunteers von Prothon, Susanne, Wählby Hamrén, Ulrika, Tehler, Ulrika, Yoon, Esther, Forsman, Henrik, Arfvidsson, Cecilia, Aggarwal, Ajay, Chen, Yingxue

Volltext

Longitudinal FEV1 and Exacerbation Risk in COPD: Quantifying the Association Using Joint Modelling von Zhudenkov, Kirill, Palmér, Robert, Jauhiainen, Alexandra, Helmlinger, Gabriel, Stepanov, Oleg, Peskov, Kirill, Eriksson, Ulf G, Wählby Hamrén, Ulrika

Volltext

A PET study comparing receptor occupancy by five selective cannabinoid 1 receptor antagonists in non-human primates von Hjorth, Stephan, Karlsson, Cecilia, Jucaite, Aurelija, Varnäs, Katarina, Wählby Hamrén, Ulrika, Johnström, Peter, Gulyás, Balázs, Donohue, Sean R., Pike, Victor W., Halldin, Christer, Farde, Lars

Volltext

Population Pharmacokinetics of Nirsevimab in Preterm and Term Infants von Clegg, Lindsay, Freshwater, Ed, Leach, Amanda, Villafana, Tonya, Hamrén, Ulrika Wählby

Volltext

Longitudinal [FEV.sub.1] and Exacerbation Risk in COPD: Quantifying the Association Using Joint Modelling von Zhudenkov, Kirill, Palmer, Robert, Jauhiainen, Alexandra, Helmlinger, Gabriel, Stepanov, Oleg, Peskov, Kirill, Eriksson, Ulf G, Hamren, Ulrika Wahlby

Volltext

Exposure vs. response of blood pressure in patients with rheumatoid arthritis following treatment with fostamatinib von Boström, Emma, Öhrn, Fredrik, Hanze, Eva, Sandström, Marie, Martin, Paul, Wählby-Hamrén, Ulrika

Volltext

Safety and Pharmacokinetics of Nirsevimab in Immunocompromised Children von Domachowske, Joseph, Hamrén, Ulrika Wählby, Banu, Irfana, Baronio, Roberta, Basavaraju, Bhanu, Koen, Anthonet, Leach, Amanda, Mankad, Vaishali S, Pannaraj, Pia S, Soler-Palacin, Pere, Takas, Therese, Mori, Masaaki, Villafana, Tonya

Volltext

The novel bronchodilator navafenterol: a phase 2a, multicentre, randomised, double-blind, placebo-controlled crossover trial in COPD von Singh, Dave, Beier, Jutta, Astbury, Carol, Belvisi, Maria G, Da Silva, Carla A, Jauhiainen, Alexandra, Jimenez, Eulalia, Lei, Alejhandra, Necander, Sofia, Smith, Jaclyn A, Wählby Hamrén, Ulrika, Xin, Wenjing, Psallidas, Ioannis

Volltext

Safety of Re-dosing Nirsevimab Prior to RSV Season 2 in Children With Heart or Lung Disease von Domachowske, Joseph B, Chang, Yue, Atanasova, Victoria, Cabañas, Fernando, Furuno, Kenji, Nguyen, Kim A, Banu, Irfana, Kubiak, Robert J, Leach, Amanda, Mankad, Vaishali S, Shroff, Manish, Takas, Therese, Villafana, Tonya, Wählby Hamrén, Ulrika

Volltext

Navafenterol (AZD8871) in patients with COPD: a randomized, double-blind, phase I study evaluating safety and pharmacodynamics of single doses of this novel, inhaled, long-acting,... von Singh, Dave, Balaguer, Victor, Astbury, Carol, Wählby-Hamrén, Ulrika, Jimenez, Eulalia, Seoane, Beatriz, Villarroel, Cristina, Lei, Alejhandra, Aggarwal, Ajay, Psallidas, Ioannis

Volltext